Our results also indicated that MRCCAT1 inhibits the mRNA levels of NPR3 through binding to EZH2, and then promotes the activation of p38-MAPK signaling and ccRCC cell metastasis. The gene discussed is ELL2; the disease is nonpapillary renal cell carcinoma.